Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2018-05-04 History
Report ID 46287
Drug Identification Number 02439131
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 36G 4.5G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 VIAL
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-04-18
Estimated end date 2018-05-01
Actual end date 2018-05-03
Shortage status Resolved
Updated date 2018-05-04
Company comments Product is available
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-05-04 English Compare
v8 2018-05-03 French Compare
v7 2018-05-03 English Compare
v6 2018-04-26 English Compare
v5 2018-04-25 French Compare
v4 2018-04-25 English Compare
v3 2018-04-19 English Compare
v2 2018-04-18 French Compare
v1 2018-04-18 English Compare